SLC2A1 and neoplasm: HIF has been confirmed to be involved in the glycolytic pathway of tumor cells, and it can directly upregulate the expression of glycolysis-related transporters and key enzymes such as GLUT, PFK, LDH, HK, etc. (Song et al., 2016).